Koyfin Home > Directory > Health Care > Adma Biologics > EV / Sales (ltm)

Adma Biologics EV / Sales (ltm) Chart (ADMA)

Adma Biologics annual/quarterly EV / Sales (ltm) from 2013 to 2020.
  • Adma Biologics EV / Sales (ltm) for the quarter ending September 09, 2020 was 5.67 a 2.04% increase of 0.12 year over year
  • Adma Biologics EV / Sales (ltm) for the last 12 months ending September 09, 2020 was 5.67 a 2.04% increase of 0.12 year over year
  • Adma Biologics Annual EV / Sales (ltm) for 2020 was 5.67 a -0.41% decrease of -0.02 from 2019
  • Adma Biologics Annual EV / Sales (ltm) for 2020 was 5.70 a 5.70% increase of 0.32 from 2019
  • Adma Biologics Annual EV / Sales (ltm) for 2020 was 5.37 a -3.45% decrease of -0.19 from 2019
Other Valuation Metrics:
  • Adma Biologics Market Cap for the quarter ending March 03, 2018 was $208m a 54.25% increase of 113m year over year
  • Adma Biologics Price / Book for the quarter ending March 03, 2018 was 5.17 a -360.96% decrease of -18.66 year over year
  • Adma Biologics Enterprise Value for the quarter ending March 03, 2018 was $206m a 49.35% increase of 101m year over year
View Chart On Koyfin

Quarterly ADMA EV / Sales (ltm) Data

09/20205.67
09/20205.70
09/20205.37
09/20205.56
09/20205.81
09/20205.88
09/20206.16
09/20206.23
09/20206.21
09/20206.07

Annual ADMA EV / Sales (ltm) Data

20205.67
20205.70
20205.37
20205.56
20205.81
20205.88
20206.16
20206.23
20206.21
20206.07